Go Pro
NASDAQ:NEPH

Nephros Q1 2025 Earnings Report

Nephros logo
$4.31 +0.08 (+1.89%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$4.31 +0.00 (+0.09%)
As of 09/18/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nephros EPS Results

Actual EPS
$0.05
Consensus EPS
-$0.01
Beat/Miss
Beat by +$0.06
One Year Ago EPS
N/A

Nephros Revenue Results

Actual Revenue
$4.88 million
Expected Revenue
$3.67 million
Beat/Miss
Beat by +$1.21 million
YoY Revenue Growth
N/A

Nephros Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
4:00PM ET

Upcoming Earnings

Nephros' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Nephros Earnings Headlines

Nephros (NASDAQ:NEPH) Trading 7.4% Higher - Should You Buy?
Nephros (NEPH) Q2 2026 Earnings Call Transcript
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.tc pixel
Nephros, Inc. (NEPH) Q2 2026 Earnings Call Transcript
See More Nephros Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nephros? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nephros and other key companies, straight to your email.

About Nephros

Nephros (NASDAQ:NEPH), Inc. (NASDAQ:NEPH) is a medical device company that develops and sells filtration products designed to purify water and other biological fluids. Its technologies are used in healthcare settings and other applications where reducing microbial contamination and impurities is important.

The company’s product portfolio includes ultrafiltration systems and replacement filters for hemodialysis applications, as well as water-filtration products used in hospitals and other healthcare facilities. Nephros also offers filtration solutions intended to support infection-control programs, including products designed for point-of-use water treatment.

Nephros serves healthcare providers, dialysis organizations, hospitals, distributors and commercial customers, primarily through the United States market. Its business has historically focused on applying membrane-filtration technology to improve water quality and support patient-care and facility-management needs.

View Nephros Profile